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Thrombin is a Na + -activated allosteric enzyme (1) that carries out diverse and even opposing functions in the blood. The Na + -bound fast form is responsible for the procoagulant and prothrombotic roles of thrombin, and shows high specificity toward fibrinogen and the platelet receptor PAR1 (2) . On the other hand, the Na + -free slow form cleaves fibrinogen and the platelet receptors with low specificity, but retains high specificity toward the anticoagulant protein C (2) . The partitioning of thrombin functions between the anticoagulant slow and procoagulant fast forms is of enormous physiologic importance. In fact, under physiologic conditions of pH and temperature, the K d for Na + binding is 110 mM (3) and approaches the concentration of NaCl in the blood (145 mM). This makes the slow and fast forms almost equally populated in vivo (2:3 ratio) and ensures that the slow↔fast equilibrium is optimally posed for allosteric regulation by cofactors like fibrin (procoagulant) and heparin (anticoagulant). Indeed, natural mutations that alter the slow↔fast equilibrium by compromising Na + binding are associated with bleeding phenotypes (4) and practically every mutant of thrombin reported to-date with reduced Na + binding capabilities shows compromised fibrinogen clotting and PAR1 activation, but little effect on protein C activation (4, 5) . As an important validation of the allosteric nature of the enzyme and the role of Na + binding in switching the specificity from anticoagulant (protein C) to procoagulant (fibrinogen) substrates (6) , thrombin can be rationally engineered to act predominantly or exclusively on protein C by abrogating its Na + binding capabilities (7) (8) (9) . Some of these mutants, stabilized in the slow form, function as potent anticoagulants and antithrombotics in vivo (7, 10) .
Although almost half of the thrombin molecules in vivo exist in the Na + -free slow form, structural studies have so far been confined exclusively to the Na + -bound fast form. Pioneering structures of thrombin inhibited at the active site with the substrate analog H-D-Phe-Pro-Arg-CH 3 Cl (PPACK) (11) , or at exosite I with the hirudin Cterminal fragment hirugen (12) , have been of paramount importance in our understanding of thrombin interactions with substrates and inhibitors. These structures have been solved in the presence of Na stability of the sample under crystallization conditions and rapidly degrades or even impairs crystal growth. On the other hand, the reason why Na + was used in the buffer of practically all published structures of thrombin is less clear, as it is not obvious that this cation is needed for crystallization. However, in order to obtain a structure of the Na + -free slow form, it is not sufficient to eliminate Na + from the buffer. In fact, practically all active-site or exosite I inhibitors of thrombin bind preferentially to the fast form (2) and, therefore, a thrombin structure solved in the presence of inhibitors like PPACK, hirudin or hirugen would be biased toward the fast form, even in the absence of Na + .
In order to eliminate the need for inhibition of the enzyme by synthetic or natural inhibitors, the thrombin mutant S195A inactivated at the active site S195 has been crystallized recently (14) . However, it has been shown that Ala mutations of residues of the catalytic triad in subtilisin drastically reduce but do not abrogate catalytic activity (15) . Not surprisingly, the S195A mutant of thrombin has shown appreciable catalytic activity over the long time frame required for crystallization (14) , thereby preventing its use as a viable reagent for further crystallization studies without inhibitors.
In this study, we made thrombin resistant to proteolytic digestion by replacing R77a in exosite I with Ala.
This enabled the structure of the enzyme to be solved without inhibitors for the first time. In addition, crystals were grown in a buffer free of NaCl and monovalent cations, from which the unprecedented structure of the anticoagulant slow form of thrombin in the free state could be resolved.
Materials and Methods
Site-directed mutagenesis of human α-thrombin was carried out in a HPC4-pNUT expression vector, using the Quikchange Site-directed Mutagenesis Kit from Stratagene. Expression of the R77aA mutant was carried out in baby hamster kidney cells (8, 9) . The enzyme was activated with the prothrombinase complex for 30 min at 37 °C and was purified to homogeneity by FPLC using Resource Q and S columns with a linear gradient from 0.05 to 0.5 M choline chloride, 5 mM MES, pH 6 at room temperature. The mutant was checked for incomplete activation and/or autolytic digestion by N-terminal amino acid sequencing. The active site concentration was determined by titration with hirudin and was found to be 99%. Structures were solved by molecular replacement using the coordinates of the thrombin-PPACK complex (11) and the program package CNS (18) . Crystallographic refinement was carried out by simulated annealing and conjugated-gradient minimization using CNS, and model building was performed with the program "O" (19) .
Residues 1h-1c, 14l-15, 148-149e, and 246-247 could not be resolved and were not included in subsequent refinement. Water molecules were added in the final stage of the refinement process. They were subject to visual inspection to check their positioning in electron density and allowed to refine freely. Water molecules with temperature factor (B-factor) higher than 70 Å6
Coordinates of the structure of the R77aA thrombin mutant have been deposited to the Protein Data Bank (accession code 1XXX).
Results
The mutant R77aA is functionally equivalent to wild-type in all interactions that do not involve exosite I (Table 1) . Cleavage of FPR and protein C are the same as in wild-type, and so is Na with a modest, highly localized perturbation of exosite I that does not affect the active site and the Na + binding environment. We therefore expected the R77aA mutant to be an excellent reagent for crystallization studies in the absence of inhibitors and Na + .
The structure of R77aA was solved at 2.8 Å resolution by molecular replacement using the coordinates of PPACK-inhibited thrombin 1PPB (11) . Details of the crystallization are given in Table 2 . The overall fold of the R77aA mutant in the Na + -free slow form is practically identical to that of the fast form inhibited with PPACK and the backbone r.m.s. between the two structures is 0.5 Å (Figure 1 ). The autolysis loop is quite disordered, as usually found in thrombin structures, and the segment 148-149e could not be traced from the electron density map. With this exception, the backbone of the R77aA mutant is intact and shows no signs of proteolytic cleavage. The crystal packing does not block the active site and puts no significant constraints on the conformation of the enzyme. This proves for the first time that thrombin can be crystallized in the absence of inhibitors, once proteolytic cleavage at R77a in exosite I is prevented.
Because Na + or other monovalent cations were not included in the crystallization buffer, the structure of the R77aA reports the conformation of the anticoagulant slow form of thrombin. This conformation differs little from that of the fast form inhibited with PPACK (11) or hirugen (12) at the level of the backbone traces, but bears a number of subtle changes that fully explain its functional properties. At the resolution limits of the crystal, the Na + environment shows a conspicuous paucity of solvent molecules (Figure 2A ), especially in the channel embedding the S1 specificity site that is highly hydrated in the fast 7 form (20). Well defined density however exists for the backbone around the loop segments 220-224 and 186-187 that define the Na + binding site (21) . These loops assume the same conformation as in the fast form, suggesting an intrinsic rigidity that is not altered by the slow→fast transition.
The absence of Na + has a direct effect on the conformation of D189 at the bottom of the primary specificity pocket S1 (Figure 2A,B) . In the fast form, a water molecule bridges the bound Na + to the Oδ2 atom of D189 (12, 21) , providing an important structural link between the cation and the primary arbiter of thrombin specificity. In the slow form, this linking water molecule and Na + are replaced by w708 (Figure 2A The downward shift of the 190-193 backbone propagates to the critical residue S195 of the catalytic triad ( Figure 3A) . Notably, the Oγ of S195 rotates 54° and moves 1. Figure 3B ), which is a structural hallmark of serine proteases (22) . The interatomic distance between the Oγ of S195 and the Nε2 of H57 is 3.6 Å in the slow form, as opposed to 2.9 Å in the fast form. Finally, the shift in the position of S195 brings the Oγ within steric clash with the Cα of the P1 residue of incoming substrate ( Figure 3B ), again presaging a less than optimal interaction with substrate.
Discussion
The results reported in this study fill an important gap in our understanding of the structural components of thrombin function. Although more than 150 structures of this enzyme have been solved since the pioneering work of Bode (11) and Tulinsky (12), remarkably little insight has been gained structurally on the conformation of the enzyme in the absence of Na + or inhibitors. The structure of the R77aA mutant reveals for the first time the conformation of the Na + -free slow form of thrombin in the absence of any inhibitor.
Overall, the structure of the free slow form of thrombin shows little changes compared to the fast form bound at the active site (11) or exosite I (12) . This suggests that the structural basis of the substantial differences observed in the enzymatic properties of the slow and fast forms of thrombin (1,2) is borne out by a set of small concerted changes that reduce the ability of the enzyme to interact with substrate. These changes affect regions that have long been recognized to be crucial for substrate recognition and to finetune specificity in the entire class of serine proteases (22) . Residue D189 defines and controls S1 specificity.
The release of Na + from its site nestled between the 220-and 186-loops (21) causes the side chain of D189 to slightly bend into the cavity hosting the cation and to re-arrange its side chain in a way that would weaken the electrostatic coupling with the guanidinium group of the Arg at P1 of an incoming substrate.
This change, never before documented in a thrombin structure, would suffice to explain the reduced specificity of the slow form toward synthetic and natural substrates that penetrate the S1 pocket (1,2).
Furthermore, it suggests that the Ala mutant of D189 should practically see the differences between the slow and fast forms drastically reduced because the conformational change of D189 involves predominantly the carboxylate moiety. Indeed, substrate hydrolysis by the D189A mutant of thrombin shows no difference between the slow and fast forms (Cantwell and Di Cera, to be published).
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The perturbation originating at D189 extends to E192 that shifts its side chain away from its orientation in the PPACK-inhibited fast form (11) to assume a conformation similar to that seen in the hirugen-inhibited fast form (12) . The perturbation then extends to the active site S195 and breaks the crucial H-bonding interaction with H57. Some structural changes seem necessary to correct this "relaxed" conformation of S195 and restore the H-bond with H57, and perhaps are induced by the binding of substrate itself. The energetic cost of these changes should contribute to the lower substrate specificity of the slow form.
The reduced electrostatic coupling due to rearrangement of D189 and the energetic cost of realigning S195 for optimal substrate docking and catalysis should result in weaker substrate binding and acylation in the slow form. Indeed, the kinetic signatures of the slow→fast conversion of thrombin include a drastic increase in the rate of diffusion of substrate into the active site and a significant enhancement in the rate of acylation (1, 23) . The rearrangement of D189 and the changes around S195 point to a concerted conformational change that explains the reduced specificity of the slow form toward synthetic substrates, fibrinogen and PAR1. Three dimensional models of the thrombin-fibrinogen (24) and thrombin-PAR1 (16) complexes have been developed recently using the structure of thrombin in the fast form. When the same fragments of fibrinogen and PAR1 are docked into the active site of the slow form, the ion-pair between Arg at P1 of either substrate and the side chain of D189 appears too long and weak and the Cα atom of the Arg residue at P1 sits too close to the Oγ atom of S195.
The structure of the slow form of thrombin also provides a possible explanation for the peculiar properties of this form toward protein C. The most remarkable property of the slow form is in fact its ability to retain specificity toward the anticoagulant protein C, with or without thrombomodulin, whereas cleavage of fibrinogen and PAR1 is compromised up to 40-fold (2,6). There is currently no structural information on thrombin bound to protein C and it is difficult to assess if protein C binds to the active site of thrombin in a way that can offset the more demanding environment of the S1 site in the slow form. On the other hand, the observed shift in the side chain of E192 reveals the strategy used by thrombin to maintain specificity toward protein C in the slow form. This residue has been suggested to hinder protein C activation by providing electrostatic repulsion to residues D167 and D172 at the P3 and P3' positions of protein C (25) .
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Mutation of E192 to Gln, the residue found in trypsin, results in a 20-fold enhancement of protein C cleavage by thrombin in the absence of thrombomodulin (25) . Replacement of D167 with Phe and D172 with Asn in protein C enhances protein C activation by thrombin in the absence of thrombomodulin (26), just as seen for the E192Q thrombin mutant. It is therefore possible that thrombomodulin binding relieves the unfavorable electrostatic coupling between E192 of thrombin and the P3 and P3' residues of protein C, perhaps by reorienting the side chain of E192. There is currently conflicting structural support to this hypothesis. The recent structure of the fast form of thrombin bound to thrombomodulin does not document changes in the position of E192 (27) , but the structure of the fast form inhibited with hirugen shows a drastic rearrangement of the side chain of E192 (12) . Thrombomodulin and hirugen affect the energetics of substrate recognition at the S1-S3 sites in a practically identical manner (28), and E192 is within H-bonding distance of the charged amino terminus of small tripeptide substrates employed in kinetic studies of thrombin (29) . It would be of interest to see if movement of E192 is indeed seen in a structure of the slow form of thrombin bound to thrombomodulin.
The results emerging from the slow form of thrombin in the absence of any inhibitor or ligand bound to the active site or exosite I suggests that this conformation of thrombin is pre-configured for optimal interaction with protein C, with the side chain of E192 moved away from potential electrostatic clash with the P3 and P3' residues of protein C. If the rearrangement of E192 enhances protein C activation as seen in the E192Q mutant (25) , then a compensation is created for the decrease in specificity caused by the structural changes around D189 and S195. This would result in an enzyme that has practically the same specificity for protein C in either the slow and fast forms (2, 6) . A prediction from this model is that the enhancement of protein C activation seen in the E192Q mutant relative to wild type, in the absence of thrombomodulin, should be less pronounced in the slow form where E192 is oriented to relieve unfavorable electrostatic coupling with the P3 and P3' residues of protein C. Measurements of protein C activation by Shown are the regions in contact with substrate (orange, shown with the P1-P3 residues) that are affected by the slow→fast transition, i.e., the side chain of D189 and S195. Note how the shift in the position of S195
breaks the H-bond with H57, whose imidazole group also rotates slightly relative to the position in the fast form. The Oγ atom of S195 in the slow form moves too close to the Cα atom of the P1 residue of substrate.
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